¼¼°èÀÇ ¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀå
Pediatric Critical Care
»óǰÄÚµå : 1777420
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 300 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀåÀº 2030³â±îÁö 368¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 279¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼Ò¾Æ ÁßȯÀÚ Ä¡·á ¼¼°è ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 4.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 368¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠȣÈí±â´Â CAGR 6.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 103¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 76¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀåÀº 2024³â¿¡ 76¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.9%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 78¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.9%¿Í 3.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.8%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼Ò¾Æ ÁßȯÀÚ Ä¡·á°¡ Çö´ë ÀÇÇп¡¼­ Áß¿äÇÑ ÇÁ·ÐƼ¾îÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼Ò¾Æ ÁßȯÀÚ Ä¡·á´Â Àü ¼¼°è ÀÇ·á ºÐ¾ß¿¡¼­ °¡Àå ÀÚ¿ø Áý¾àÀûÀ̰í, ±â¼ú Áß½ÉÀûÀ̸ç, ÀÇÇÐÀûÀ¸·Î º¹ÀâÇÑ Àü¹® ºÐ¾ß Áß ÇϳªÀÔ´Ï´Ù. È£ÈíºÎÀü, ÆÐÇ÷Áõ, ¿Ü»ó¼º ³ú¼Õ»ó, ¼±Ãµ¼º ±âÇü, ½ÉÀå ±â´É Àå¾Ö, ´ë¼ö¼ú ÈÄ È¸º¹ µî »ý¸íÀ» À§ÇùÇÏ´Â »óÅ¿¡ ÀÖ´Â ¿µ¾Æ, ¼Ò¾Æ, û¼Ò³âÀ» ÁýÁß ¸ð´ÏÅ͸µÇϰí Ä¡·áÇÕ´Ï´Ù. ¼ºÀÎ ÁßȯÀڽǰú ´Þ¸® ¼Ò¾Æ ÁßȯÀÚ½Ç(PICU)¿¡¼­´Â ±Þº¯ÇÏ´Â »ý¸®Àû ±â´É, ¹Ì¼º¼÷ÇÑ Àå±â °èÅë, üÁß¿¡ µû¸¥ ¾à¹° ¿ë·®ÀÇ Å« º¯µ¿ µîÀÇ ¹®Á¦¸¦ ÇØ°áÇØ¾ß ÇÕ´Ï´Ù. PICU¿¡¼­´Â ÀϹÝÀûÀ¸·Î ±â°è½Ä ÀΰøÈ£Èí±â, ü¿Ü¸· »ê¼ÒÈ­¿ä¹ý(ECMO), Áö¼ÓÀû ½Å´ëü¿ä¹ý(CRRT), ħ½ÀÀû Ç÷¿ªÇÐ ¸ð´ÏÅ͸µ ÀåÄ¡ µî ÷´Ü »ý¸íÀ¯Áö°ü¸® ½Ã½ºÅÛÀÌ »ç¿ëµÇ¸ç, ÀÌ ¸ðµç °ÍÀº ¼Ò¾ÆÀÇ »ý¸®Àû ±â´É¿¡ ¸Â°Ô Á¶Á¤µË´Ï´Ù. ÁßÁõ ¼Ò¾Æ ȯÀÚÀÇ °ü¸®´Â ½Å¼ÓÇÑ Áø´Ü, ¿¬·É¿¡ ¸Â´Â ÁøÁ¤ ÇÁ·ÎÅäÄÝ, °¡Á· Áß½É Ä¡·á ¿øÄ¢ÀÇ ÅëÇÕÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ´õ¿í º¹ÀâÇØÁ³½À´Ï´Ù. ¼¼°èÀûÀÎ Ãß¼¼´Â ¹Ì¼÷¾Æ »ýÁ¸À² Áõ°¡, ¼Ò¾Æ ¿Ü»ó, ¼±Ãµ¼º ½ÉÀåÁúȯ, ¸¸¼º È£Èí±â Áúȯ µîÀ¸·Î ÀÎÇØ ¼Ò¾Æ ÁßÁõȯÀÚÀÇ ºÎ´ãÀÌ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÓ»óÀû ºÎ´ãÀº ƯÈ÷ µµ½Ã º´¿ø, ´ëÇк´¿ø, ´ëÇÐ ÀÇ·á¼¾ÅÍ, µ¶¸³Çü ¼Ò¾Æ°ú ½Ã¼³¿¡¼­ PICU È®ÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. Àü´ã ¼Ò¾ÆÁýÁßÄ¡·á»ç, ¾à»ç, È£ÈíÄ¡·á»ç, ¿µ¾ç»ç, ¼Ò¾Æ»ýȰÀü¹®°¡ µî ´ÙÇÐÁ¦ Áø·áÆÀÀÇ Á¸Àç´Â ÀÌ ºÐ¾ßÀÇ ´ÙÂ÷¿øÀû Ư¼ºÀ» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÁßȯÀÚ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, ¼Ò¾Æ ºÎ¹®Àº ÀÇ·á Á¤Ã¥ ¹× º´¿ø ÀÎÇÁ¶ó °èȹ ¸ðµÎ¿¡¼­ ÃÖ¿ì¼± ¼øÀ§·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¼Ò¾Æ ÁßȯÀÚ½ÇÀ» ¾î¶»°Ô °³ÇõÇϰí Àִ°¡?

¼Ò¾Æ ÁßȯÀÚ Ä¡·áÀÇ Çõ½ÅÀº »ý¸íÀ¯Áö¸¦ À§ÇÑ °³ÀÔÀÇ Á¤È®¼º, ¾ÈÀü¼º, È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ ºü¸¥ ±â¼ú Çõ½Å¿¡ ÀÇÇØ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ½Å»ý¾Æ ¹× ¼Ò¾Æ ¸ðµå¸¦ °®Ãá Â÷¼¼´ë ÀΰøÈ£Èí±â, ÈÞ´ë¿ë ECMO ½Ã½ºÅÛ, ÅëÇÕ È¯ÀÚ ¸ð´ÏÅ͸µ Ç÷§ÆûÀº ÷´Ü PICUÀÇ Ç¥ÁØÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ½Ç½Ã°£ ºÐ¼®, Á¶±â °æº¸ Á¡¼ö, ¸ÂÃãÇü ´ë½Ãº¸µå¸¦ Á¦°øÇÏ¿© ÁßȯÀÚ½Ç Àǻ簡 µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ ½Å¼ÓÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¿¹Ãø ºÐ¼®Àº ƯÈ÷ ÆÐÇ÷Áõ°ú ±Þ¼º È£ÈíºÎÀü »ç·Ê¿¡¼­ ÀÓ»óÀûÀ¸·Î ¸í¹éÈ÷ µå·¯³ª±â Àü¿¡ ȯÀÚÀÇ ¾ÇÈ­¸¦ ½Äº°ÇÏ´Â µ¥ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ħ»ó ÃÊÀ½ÆÄ °Ë»ç, Ç÷¾×°¡½º ½Å¼Ó ºÐ¼®±â, ½Ç½Ã°£ ÀÀ°í ¸ð´ÏÅÍ µîÀÇ ÇöÀå Áø´ÜÀ» ÅëÇØ Ä¡·á ½Ã°£À» ´ÜÃàÇϰí ÀÀ±Þ »óȲ¿¡¼­ÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ·Îº¿ °øÇÐ ¹× ÀÚµ¿ ¾à¹° Àü´Þ ½Ã½ºÅÛµµ ÁßȯÀÚ½Ç ¿öÅ©Ç÷ο쿡 ½Ã¹üÀûÀ¸·Î µµÀԵǾî Åõ¾à ¿À·ù¸¦ ÁÙÀ̰í, ƯÈ÷ Ç÷°ü¾Ð¹ÚÁ¦ ¹× ÁøÁ¤Á¦ ÁÖÀÔ ¼Óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¼¾¼­¿Í ¿ø°Ý ÃøÁ¤ µµ±¸´Â ¹ÙÀÌÅ» ÆÄ¶ó¹ÌÅÍÀÇ Áö¼ÓÀûÀÎ ¿ø°Ý ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô Çϰí, º´¿ø ³» ¹× ½ºÅÜ´Ù¿î ȯ°æ¿¡¼­ Á¶±â °³ÀÔÀ» Áö¿øÇÕ´Ï´Ù. ÇöÀç ¸¹Àº PICU°¡ Áß¾ÓÁýÁᫎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» µµÀÔÇÏ¿© ÇÑ Á¦¾î½Ç¿¡¼­ ¿©·¯ ȯÀÚÀÇ µ¥ÀÌÅ͸¦ °üÂûÇÏ°í °ü¸®ÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀüÀÚÀǹ«±â·Ï(EHR), ÀÓ»óÆÇ´ÜÁö¿øµµ±¸, Åõ¾à°ü¸® Ç÷§ÆûÀÇ µðÁöÅÐ ÅëÇÕÀ» ÅëÇØ ¾÷¹« °£¼ÒÈ­, ÄÄÇöóÀ̾𽺠Çâ»ó, Áߺ¹¼º °¨¼Ò¸¦ ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¹× AI·Î °­È­µÈ ÁßȯÀÚ Ä¡·á »ýŰ迡 ÅõÀÚÇÏ´Â º´¿øÀÌ ´Ã¾î³²¿¡ µû¶ó, ¹Ì·¡ÀÇ PICU´Â ¹ÝÀÀ¼ºÀÌ Çâ»óµÉ »Ó¸¸ ¾Æ´Ï¶ó ¿¹Ãø, °³ÀÎÈ­, ÇÁ·ÎÅäÄÝ ±â¹ÝÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿Ö Ä¡·á ¸ðµ¨ÀÌ ´ÙÇÐÁ¦Àû, °¡Á· Áß½ÉÀÇ ÁßÁõ Ä¡·á·Î ÀüȯµÇ°í Àִ°¡?

¼Ò¾Æ ÁßȯÀÚ Ä¡·áÀÇ Á¦°øÀº Á¡Á¡ ´õ »çÀÏ·ÎÈ­µÈ ÀÓ»óÀû °³ÀÔ¿¡¼­ ÅëÇÕµÈ ´ÙÇÐÁ¦Àû, °¡Á· Áß½ÉÀÇ Ä¡·á ¸ðµ¨·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁøÈ­ÀÇ ¹è°æ¿¡´Â ÁßÁõ ¾Æµ¿Àº ÀÇÇÐÀû Ä¡·á¿Í º´ÇàÇÏ¿© Á¤¼­Àû, ¹ß´ÞÀû, ½É¸®»çȸÀû Çʿ並 ÃæÁ·½Ãų ¼ö Àִ ȯ°æ¿¡¼­ ´õ Àß È¸º¹µÈ´Ù´Â ÀνÄÀÌ ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ¿À´Ã³¯ PICU¿¡¼­´Â ÁýÁßÄ¡·á Àü¹®ÀÇ, °£È£»ç, »çȸº¹Áö»ç, Ä¡·á»ç, °¡Á·µéÀÌ ÇÔ²² ȸÁø¿¡ Âü¿©ÇÏ¿© Ä¡·á¿¡ ´ëÇÑ ³íÀǸ¦ ÇÏ´Â °øµ¿ ȸÁøÀ» Áß¿ä½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ÆÀÀº ¼Ò¾ÆÀÇ Àå±âÀûÀÎ °á°ú¸¦ °í·ÁÇÑ Ä¡·á °èȹÀ» ¼ö¸³Çϰí PICU Åð¿ø ÈÄ ÀÎÁöÀû, Á¤¼­Àû, ½ÅüÀû Àå¾Ö¸¦ Æ÷ÇÔÇÑ ¼Ò¾Æ ÁýÁßÄ¡·á ÈÄ ÁõÈıº(PICS-p)ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ Çù·ÂÇϰí ÀÖ½À´Ï´Ù. ¼±Ãµ¼º ½ÉÀåÁúȯ, ¿Ü»ó¼º ³ú¼Õ»ó, ´Ù¹ß¼º Àå±âºÎÀü µî º¹ÀâÇÑ º´Å¿¡ ´ëÇØ¼­´Â Àü¹®ÀûÀÎ Ä¡·á °æ·Î°¡ µµÀԵǰí ÀÖ½À´Ï´Ù. º´¿øÀº ¶ÇÇÑ 24½Ã°£ ºÎ¸ð¸¦ ¼ö¿ëÇϰí, º´»ó °£È£¿¡ °¡Á·ÀÌ ½±°Ô Âü¿©ÇÒ ¼ö ÀÖµµ·Ï Çϰí, ½ºÆ®·¹½º¸¦ ÁÙÀÌ°í ¹ß´ÞÀÇ ¿¬¼Ó¼ºÀ» Áö¿øÇϱâ À§ÇØ ³îÀÌÄ¡·á, À½¾ÇÄ¡·á, ±³À°À» µµÀÔÇÑ ÀÎÇÁ¶ó¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ ÁøÁ¤ ¹× ÅëÁõ °ü¸® ÇÁ·ÎÅäÄÝÀº ºñ¾à¸®ÇÐÀû Àü·«°ú È¿°úÀûÀÎ ÅëÁõ Æò°¡ µµ±¸ÀÇ »ç¿ëÀÌ Áõ°¡Çϸ鼭 ´õ¿í Á¤±³ÇØÁö°í ÀÖ½À´Ï´Ù. ÁßÀú¼Òµæ ±¹°¡¿¡¼­´Â ±¸Á¶È­µÈ ÁßȯÀÚ Ä¡·á ±³À° ÇÁ·Î±×·¥°ú ¿ø°Ý PICUÀÇ »ç¿ëÀÌ Áõ°¡ÇÏ¿© ¼Ò¾Æ ÁßȯÀÚ Ä¡·á Àü¹® Áö½ÄÀÇ °ÝÂ÷¸¦ ÇØ¼ÒÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è ÀÇ·á±â°üµéÀº ÁßȯÀÚ Ä¡·á Á¦°øÀÇ ¸ð¹ü »ç·Ê¸¦ º¸ÀåÇϱâ À§ÇØ ÄÉ¾î ¹øµé, ½Ã¹Ä·¹ÀÌ¼Ç ±³À°, °øµ¿ °á°ú µî·ÏÀ» ÅëÇØ Ç¥ÁØÈ­¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á ¸ðµ¨ÀÇ Àü¹ÝÀûÀÎ ÀüȯÀº ÀÓ»óÀû °á°ú»Ó¸¸ ¾Æ´Ï¶ó ÀþÀº ȯÀÚ¿Í ±× °¡Á·ÀÇ °æÇè°ú ¸¸Á·µµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Çõ½Å, ÃÖÁ¾ »ç¿ë ¿ªÇÐÀÇ ÁøÈ­, ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ´ëÇÑ ¼ÒºñÀÚ ±â´ëÄ¡ÀÇ º¯È­¿Í °ü·ÃµÈ ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ½Å»ý¾Æ ÇÕº´Áõ, ¿Ü»ó, È£Èí±â °¨¿°, ¼±Ãµ¼º ½ÉÀ庴 µî ÁýÁßÀûÀÎ ¸ð´ÏÅ͸µ°ú ÁßÀç°¡ ÇÊ¿äÇÑ ¼Ò¾Æ ÁßÁõ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¿µ»ó Áø´Ü, ½Ç½Ã°£ ºÐ¼®, ¼Ò¾Æ Àü¿ë »ý¸í À¯Áö ±â¼úÀÇ ¹ßÀüÀ¸·Î ÁßÁõ ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÏ°í º¸´Ù Á¤¹ÐÇÏ°Ô °ü¸®ÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó °íµµÀÇ ±Þ¼º±â ¼Ò¾Æ ÀÇ·á ȯ°æ¿¡ ´ëÇÑ ÅõÀÚ°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ Ãø¸é¿¡¼­´Â º´¿ø°ú ÀÇ·á ½Ã½ºÅÛÀÌ PICUÀÇ ¿ë·®À» È®ÀåÇϰí, ÀÏ¹Ý ÁßȯÀÚ½ÇÀ» ¼Ò¾Æ Àü¿ëÀ¸·Î °³Á¶Çϰí, ¼Ò¾Æ º´¿ø ³»¿¡ Ư¼ö ÁßȯÀÚ½ÇÀ» °³¹ßÇÏ¿© ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ ÀÇ·á ¼­ºñ½º¸¦ 3Â÷ ÀÇ·á±â°ü°ú 4Â÷ ÀÇ·á±â°ü¿¡ ÁýÁßÇÏ´Â °æÇâÀÌ °­ÇØÁö¸é¼­ °íµµÀÇ ÁßÁõ ÀǷḦ Á¦°øÇÏ´Â Áö¸®Àû °ÅÁ¡ÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ ¼Ò¾Æ ÀÌ¼ÛÆÀ, À̵¿½Ä ¿¡Å©¸ð ¼­ºñ½º, ¿ø°Ý ÀǷḦ ÀÌ¿ëÇÑ ÁßȯÀÚ Ä¡·á°¡ ºÎ»óÇϸ鼭 ÀÇ·á ÇýÅÃÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­µµ ÁßȯÀÚ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ±â´ëµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¼Ò¾Æ¿¡ ƯȭµÈ Ä¡·á ȯ°æ, Ä¡·á Á¤Ã¥ °áÁ¤ÀÇ Åõ¸í¼º Çâ»ó, ½Ç½Ã°£ ¸ð´ÏÅ͸µ Âü¿© µîÀ» ¿ä±¸ÇÏ´Â °¡Á·µéÀÇ ¸ñ¼Ò¸®°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ±³À°, ÀÎÇÁ¶ó Ç¥ÁØÈ­, °á°ú º¥Ä¡¸¶Å·À» ÃËÁøÇÏ´Â ¼¼°è ÀÌ´Ï¼ÅÆ¼ºê°¡ Àü ¼¼°èÀûÀ¸·Î ÀÇ·áÀÇ ÁúÀû ±âÁØÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â±â Á¦Á¶¾÷ü, º´¿ø ½Ã½ºÅÛ, ¿¬±¸±â°üÀÇ Çù·ÂÀ¸·Î ¼Ò¾Æ Àü¹® ÀÇ·á±â±â ¹× µðÁöÅÐ Ç÷§ÆûÀÇ °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÇÕÀûÀÎ ¿äÀεéÀÌ ¼Ò¾Æ ÁßȯÀÚ Ä¡·á ½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®ÀåÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, °í¼º´ÉÀÇ ¹è·Á½É ÀÖ´Â ¼Ò¾Æ ÀÇ·á ½Ã½ºÅÛÀÇ ÇÙ½É ¿ªÇÒÀ» ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Ä¡·á(È£Èí±â, ¼øÈ¯±â, ½Å°æ, ¼ÒÈ­±â, ±Ù°ñ°Ý°è Áúȯ, °¨¿°Áõ, Ç÷¾×, ¼±Ãµ¼º, ´ÙÀå±â ºÎÀü ÁõÈıº, ±âŸ);º´¿ø ¼ÒÀ¯ ÇüÅÂ(°ø¿µ/Á¤ºÎ ¼ÒÀ¯, ºñ¿µ¸® ¹Î°£ ¼ÒÀ¯, ¿µ¸® ¹Î°£ ¼ÒÀ¯)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pediatric Critical Care Market to Reach US$36.8 Billion by 2030

The global market for Pediatric Critical Care estimated at US$27.9 Billion in the year 2024, is expected to reach US$36.8 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Respiratory, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.3 Billion by the end of the analysis period. Growth in the Others segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 8.9% CAGR

The Pediatric Critical Care market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Pediatric Critical Care Market - Key Trends & Drivers Summarized

What Makes Pediatric Critical Care a High-Stakes Frontier in Modern Medicine?

Pediatric critical care represents one of the most resource-intensive, technology-driven, and medically complex specialties in global healthcare. It encompasses the intensive monitoring and treatment of infants, children, and adolescents with life-threatening conditions, including respiratory failure, sepsis, traumatic brain injuries, congenital anomalies, cardiac dysfunctions, and post-operative recovery after major surgeries. Unlike adult critical care, pediatric intensive care units (PICUs) must contend with rapidly changing physiology, organ system immaturity, and highly variable weight-based drug dosing-challenges that demand specialized equipment, tailored treatment protocols, and highly trained personnel. PICUs typically operate with advanced life-support systems such as mechanical ventilators, extracorporeal membrane oxygenation (ECMO), continuous renal replacement therapy (CRRT), and invasive hemodynamic monitoring devices, all calibrated for pediatric physiology. The management of critically ill pediatric patients is further complicated by the need for rapid diagnostics, age-adjusted sedation protocols, and the integration of family-centered care principles. Global trends show a rising burden of pediatric critical illnesses due to increased survival of premature infants, pediatric trauma, congenital heart disease, and chronic respiratory conditions. These clinical pressures are driving the expansion of PICUs, particularly in urban hospitals, academic medical centers, and standalone pediatric facilities. The presence of dedicated pediatric intensivists and interdisciplinary care teams-including pharmacists, respiratory therapists, nutritionists, and child life specialists-reflects the multidimensional nature of this field. As critical care demands escalate, the pediatric segment is emerging as a frontline priority in both health policy and hospital infrastructure planning.

How Are Technological Advancements Reinventing Pediatric Intensive Care Units?

The transformation of pediatric critical care is being accelerated by rapid technological innovation aimed at enhancing precision, safety, and efficiency in life-sustaining interventions. Next-generation ventilators with neonatal and pediatric modes, portable ECMO systems, and integrated patient monitoring platforms are becoming standard across advanced PICUs. These systems offer real-time analytics, early warning scores, and customizable dashboards that allow intensivists to make faster, data-driven decisions. Artificial intelligence (AI) and predictive analytics are being increasingly used to identify patient deterioration before it becomes clinically apparent, particularly in sepsis and acute respiratory failure cases. In addition, point-of-care diagnostics, such as bedside ultrasound, rapid blood gas analyzers, and real-time coagulation monitors, are shortening time-to-treatment and improving outcomes in emergency situations. Robotics and automated drug delivery systems are also being piloted in critical care workflows to reduce medication errors and ensure consistent infusion rates, especially for vasopressors and sedatives. Wearable sensors and telemetry tools allow continuous remote monitoring of vital parameters, supporting early intervention in both in-hospital and step-down settings. Many PICUs are now implementing centralized monitoring systems where data from multiple patients can be observed and managed from a single control room. Furthermore, the digital integration of electronic health records (EHRs), clinical decision support tools, and medication management platforms has streamlined operations, improved compliance, and reduced redundancies. With hospitals increasingly investing in cloud-based and AI-enhanced critical care ecosystems, the PICU of the future is expected to be not only more responsive but also predictive, personalized, and protocol-driven.

Why Are Care Models Shifting Toward Multidisciplinary and Family-Centered Critical Care?

The delivery of pediatric critical care is increasingly shifting from siloed clinical interventions to integrated, multidisciplinary, and family-inclusive care models. This evolution is driven by the recognition that critically ill children recover better in environments where emotional, developmental, and psychosocial needs are addressed alongside medical treatment. Today’s PICUs emphasize collaborative rounds that include intensivists, nurses, social workers, therapists, and family members in care discussions. These teams work collectively to design treatment plans that account for the child’s long-term outcomes, minimizing the risk of post-intensive care syndrome in pediatrics (PICS-p), which includes cognitive, emotional, and physical impairments after PICU discharge. Specialized care pathways are being implemented for complex conditions such as congenital heart defects, traumatic brain injuries, and multi-organ failure, all requiring synchronized efforts from various specialists. Hospitals are also investing in infrastructure that accommodates parents around the clock, facilitates family participation in bedside care, and incorporates play therapy, music therapy, and education to reduce stress and support developmental continuity. Pediatric sedation and pain management protocols are becoming more nuanced, with greater use of non-pharmacological strategies and validated pain assessment tools. In low- and middle-income countries, the rise of structured critical care education programs and the use of tele-PICUs are bridging the gap in pediatric critical care expertise. Moreover, global health organizations are promoting standardization through care bundles, simulation training, and collaborative outcome registries to ensure best practices in critical care delivery. The holistic shift in care models is enhancing not only clinical outcomes but also the experience and satisfaction of both young patients and their families.

The Growth in the Pediatric Critical Care Market Is Driven by Several Factors…

The growth in the pediatric critical care market is driven by several factors related to technological innovation, evolving end-use dynamics, and shifting consumer expectations in healthcare delivery. One of the primary drivers is the increasing incidence of pediatric critical illnesses, including neonatal complications, traumatic injuries, respiratory infections, and congenital heart conditions, all of which require intensive monitoring and intervention. Advances in diagnostic imaging, real-time analytics, and pediatric-specific life-support technologies are enabling earlier recognition and more targeted management of critical conditions, prompting investments in high-acuity pediatric care settings. On the end-use front, hospitals and health systems are expanding their PICU capacities, retrofitting general ICUs for pediatric use, and developing specialized critical care wings within children’s hospitals to meet rising demand. The growing trend of centralizing pediatric services in tertiary and quaternary care institutions is creating geographic hubs for advanced critical care delivery. Simultaneously, the rise of pediatric transport teams, mobile ECMO services, and telemedicine-enabled intensive care is extending access to critical care in underserved regions. Consumer expectations are also playing a key role, with families increasingly advocating for child-specific care environments, greater transparency in treatment decisions, and involvement in real-time monitoring. In parallel, global initiatives promoting pediatric critical care education, infrastructure standardization, and outcome benchmarking are raising the baseline for care quality worldwide. Furthermore, collaborations between device manufacturers, hospital systems, and research institutions are accelerating the development of pediatric-focused medical equipment and digital platforms. These combined factors are fueling a sustained expansion of the pediatric critical care market and redefining its role as a cornerstone of high-performance, compassionate pediatric healthcare systems.

SCOPE OF STUDY:

The report analyzes the Pediatric Critical Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Respiratory, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital, Multiple organ dysfunction syndrome, Others); Hospital Ownership (Publicly / Government-owned, Not-for-profit privately owned, For-profit privately owned)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â